Carlsmed, Inc. (CARL)

NASDAQ: CARL · USD

$15.4

-0.07 (-0.5%)· Recorded snapshot

Market cap	419.1M
Revenue (ttm)	63.3M
Net income (ttm)	-36.3M
EPS (ttm)	-$1.43
Shares out	27.3M
Volume	131,123

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 63.3M
Net income (ttm): -36.3M
EPS (ttm): -$1.43
Market cap: 419.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-66.1

P25 n/aP50 n/aP75 n/a

ROIC-32.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CARL indicators

Market & fundamental data

Available fields

192

Groups with data

Currency

USD

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001794546
Company name	Carlsmed, Inc.
Country	United States
Country code	US
CUSIP number	14280C105
Earnings date	2026-11-10
Earnings time	amc
Employees	127
Employees change	38
Employees growth	42.7%
Enterprise value	$351.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
In index	RUSSELL2000
Industry	Health Information Services
IPO date	2025-07-23
Is primary listing	Yes
Is SPAC	No
ISIN number	US14280C1053
Last 10-K release date	2026-02-25
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$419.1M
Market cap category	Small-Cap
Next earnings date	2026-11-10
Options	No
Price	$15.35
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	CARL
U.S. state	California
Website	https://carlsmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-9.28%
EV/Sales	5.62x
FCF / EV yield	-9.72%
FCF yield	-8.17%
Forward EV/Sales	3.85x
Forward P/S	4.57x
Industry forward P/E	34.62x
P/B ratio	4.98x
P/S ratio	6.69x
Price / tangible book value	5.02x
Sector forward P/E	23.53x
Sector P/E	51.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-61.09%
EBITDA margin	-60.44%
Gross margin	76.63%
Operating margin	-61.09%
Pretax margin	-57.42%
Profit margin	-57.42%
Profit per employee	$-286,181
Revenue per employee	$498,386
ROA	-28.19%
ROCE	-36.54%
ROE	-66.14%
ROIC	-32.32%
SBC / revenue	8.52%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	5
EPS growth years	1
Gross profit growth	71.22%
Gross profit growth (Q)	63.96%
Net income growth years	0
Revenue growth	65.39%
Revenue growth (Q)	56.75%
Revenue growth (QoQ)	17.52%
Revenue growth quarters	6
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-432,000
Depreciation and amortization	$409,000
EBIT	$-38.7M
EBITDA	$-38.3M
EPS	$-1.43
FCF per share	$-1.27
Financing cash flow	$91.4M
Free cash flow	$-34.6M
Free cash flow minus SBC	$-40M
Gross profit	$48.5M
Investing cash flow	$-44.4M
Net cash flow	$12.8M
Net income	$-36.3M
Operating cash flow minus SBC	$-39.5M
Operating income	$-38.7M
Revenue	$63.3M
Stock-based compensation	$5.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.84
Book value per share	$3.09
Debt / equity	0.26
Interest coverage	-28.98
Long-term assets	$8.6M
Long-term liabilities	$21.6M
Net cash (debt)	$67.3M
Net cash / market cap	15.9%
Net cash growth	326.94%
Net debt / equity	-0.8
Piotroski F-Score	4
Property, plant and equipment	$8.4M
Shareholders' equity	$84.2M
Tangible book value	$84.2M
Tangible book value per share	$3.09
Total assets	$118.2M
Total cash	$89.2M
Total debt	$21.9M
Total liabilities	$34M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.74
Current assets	$109.6M
Current liabilities	$12.4M
Current ratio	8.84
Inventory turnover	8.85
Net working capital	$8.7M
Quick ratio	8.31
Working capital	$97.2M
Working capital turnover	0.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-496.29%
Dividend yield	0%
Shareholder yield	-496.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$12.45
1D price change	-0.45%
1M price change	1.49%
1M total return	1.49%
1W price change	8.08%
1W total return	8.08%
1Y price change	13.18%
1Y return CAGR	13.19%
1Y total return	13.18%
20-day SMA	$14.41
200-day SMA	$12.39
3M price change	33.84%
3M total return	33.84%
50-day SMA	$15.05
50-day SMA vs 200-day SMA	50over200
52-week high	$17.23
52-week high date	2026-08-21
52-week low	$8.50
52-week low date	2026-04-29
6M price change	55.43%
6M total return	55.43%
All-time high	$17.23
All-time high date	2026-08-21
All-time low	$8.50
All-time low date	2026-04-13
Average true range (ATR)	$0.78
Average volume	81.9K
Beta (1Y)	2.36
Beta (2Y)	2.09
Change from 52-week high	-10.91%
Change from 52-week low	80.59%
Change from all-time high	-11.06%
Change from all-time low	80.29%
Change from open	0.2%
Day's gap	-0.65%
Dollar volume	$2M
High price	$15.80
Low price	$15.23
Monthly RSI	48.56
Open price	$15.32
Position in 52-week range	21.05%
Premarket change	-0.13%
Premarket close	$15.42
Premarket price	$15.40
Previous close	$15.42
Price vs 150-day SMA	23.14%
Price vs 20-day SMA	6.34%
Price vs 200-day SMA	23.73%
Price vs 50-day SMA	1.8%
Relative volume	1.6
Return from IPO open	3.33%
Return from IPO price	3.33%
RSI	58.57
Sharpe ratio	0.47
Sortino ratio	0.8
Volume	131.1K
Weekly RSI	57.41
YTD price change	24.09%
YTD total return	24.09%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15.6M
Float percentage	57.31%
Shares change (QoQ)	1.32%
Shares change (YoY)	496.29%
Shares held by insiders	12.21%
Shares held by institutions	25.37%
Shares outstanding	27.3M
Short % of float	6.74%
Short % of shares	3.86%
Short ratio	13.1 days

Deeper analysis on CARL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CARL report

Is a complete CARL research report available?

No complete published report is available for Carlsmed, Inc. (CARL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Carlsmed, Inc. (CARL)

Price

Financial snapshot

Fair-value bridge

Latest news · CARL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CARL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CARL

Frequently asked questions